| Anlotinib Hydrochloride Combined With Liposomal Doxorubicin in the Treatment of Locally Advanced or Metastatic Soft Tissue Sarcoma (NCT03880695) | Peking University People's Hospital | 2019-03-01 |
| Feasibility and Preliminary Efficacy of a Mindfulness-based Intervention for Children and Young Adults With High Grade or High-Risk Cancer and Their Caregivers (NCT03538587) | National Cancer Institute (NCI) | 2019-01-29 |
| 9-ING-41 in Patients With Advanced Cancers (NCT03678883) | Actuate Therapeutics Inc. | 2019-01-04 |
| Phase 1, First-in-human Study of Oral TP-1287 in Patients with Advanced Solid Tumors (NCT03604783) | Sumitomo Pharma America, Inc. | 2018-12-26 |
| GISAR German Interdisciplinary Sarcoma Registry (NCT04122872) | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | 2018-11-29 |
| A Study of SHR-1210 Plus Apatinib in Patients With Soft Tissue Sarcoma (NCT03711279) | Jiangsu HengRui Medicine Co., Ltd. | 2018-11-22 |
| Study of Exosomes in Monitoring Patients With Sarcoma (EXOSARC) (NCT03800121) | Centre Georges Francois Leclerc | 2018-11-19 |
| Pediatric Solid Tumor Metabolism [A Prospective Study Exploring Metabolism of Solid Tumors in Pediatrics] (NCT03686566) | University of Texas Southwestern Medical Center | 2018-11-16 |
| Diagnosis and Definition of Local Involvement of Musculoskeletal Tumors: Assessment of Ultra-high Field MRI Exploration Contribution (NCT03628274) | Assistance Publique Hopitaux De Marseille | 2018-11-01 |
| T2* MRI Analysis for Sarcoma (NCT03658343) | Bryan Allen | 2018-09-18 |
| A Trial For Participants With Ewing's Sarcoma Treated With Vigil in Combination With Irinotecan and Temozolomide (NCT03495921) | Gradalis, Inc. | 2018-08-21 |
| Immunotherapy + Radiation in Resectable Soft Tissue Sarcoma (NCT03463408) | University of Rochester | 2018-07-17 |
| Gemcitabine Plus Ascorbate for Sarcoma in Adults (NCT03468075) | Mohammed Milhem, MBBS | 2018-07-11 |
| Photoacoustic Imaging in Diagnosing Changes in Tumors in Participants With Breast Cancer, Sarcoma, Skin Cancer, or Soft Tissue Malignancy and Healthy Volunteers (NCT03630601) | Roswell Park Cancer Institute | 2018-06-28 |
| Hypofractionated Radiotherapy With Hyperthermia in Unresectable or Marginally Resectable Soft Tissue Sarcomas (NCT03989596) | Maria Sklodowska-Curie National Research Institute of Oncology | 2018-06-01 |
| Radiotherapy Concurrent With Apatinib in Advanced Soft Tissue and Bone Sarcomas of Head and Neck--RASS Study (NCT03539172) | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | 2018-06-01 |
| Analysis of Circulating Tumor Markers in Blood (NCT04025541) | Institut du Cancer de Montpellier - Val d'Aurelle | 2018-05-29 |
| Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma (NCT03465592) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2018-05-01 |
| CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers (NCT03454451) | Corvus Pharmaceuticals, Inc. | 2018-04-25 |
| Trial Comparing Active Intervention At Diagnosis With Usual Care to Improve Psycho-social Care in AYAO (NCT03515174) | National Cancer Centre, Singapore | 2018-04-16 |
| PET/MR in Assessing Response to Neoadjuvant Radiation Therapy in the Tx of High Grade Sarcomas (NCT03076333) | UNC Lineberger Comprehensive Cancer Center | 2018-04-01 |
| CBT-1® in Combination With Doxorubicin in Patients With Metastatic, Unresectable Sarcomas Who Previously Progressed on Doxorubicin (NCT03002805) | CBA Research | 2018-03-29 |
| A Study of Eribulin With Gemcitabine in Patients With Advanced Liposarcoma or Leiomyosarcoma (NCT03810976) | Yonsei University | 2018-03-27 |
| FAZA PET/MRI Sarcoma (NCT03418818) | University Health Network, Toronto | 2018-03-27 |
| REVEAL Study of NKTR-262 in Combination With NKTR-214 and Nivolumab in Patients With Locally Advanced / Metastatic Solid Tumor Malignancies (NCT03435640) | Nektar Therapeutics | 2018-03-15 |
| QUEST: QUality of Life and Experiences of Sarcoma Trajectories (NCT03441906) | Radboud University Medical Center | 2018-02-15 |
| A Study of Epacadostat, an IDO1 Inhibitor, in Combination With Pembrolizumab in Patients With Metastatic and/or Locally Advanced Sarcoma (NCT03414229) | Memorial Sloan Kettering Cancer Center | 2018-01-23 |
| The Safety and Efficacy of Combined Microwave Ablation During Limb-sparing Surgery in High-risk Soft Tissue Sarcoma Patients (NCT06802510) | Guangdong Provincial People's Hospital | 2018-01-21 |
| Anti-GD2 CAR T Cells in Pediatric Patients Affected by High Risk and/or Relapsed/Refractory Neuroblastoma or Other GD2-positive Solid Tumors (NCT03373097) | Bambino Gesù Hospital and Research Institute | 2018-01-05 |
| Pembrolizumab and Gemcitabine Chemotherapy in Leiomyosarcoma and Undifferentiated Pleomorphic Sarcoma (NCT03123276) | Royal Marsden NHS Foundation Trust | 2017-11-29 |
| Abductor Reattachment Methods in Proximal Femur Replacements: What is the Best Method? (NCT03261544) | Duke University | 2017-11-10 |
| Hyperbaric Oxygen Therapy for Soft Tissue Sarcoma Pilot Study (NCT03144206) | Duke University | 2017-10-19 |
| CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice (NCT02900248) | CureOne | 2017-10-02 |
| Burden and Medical Care of Sarcoma in Germany (NCT03521531) | Technische Universität Dresden | 2017-09-30 |
| A Study of NKTR-214 in Combination With Nivolumab in Patients With Metastatic and/or Locally Advanced Sarcoma (NCT03282344) | Memorial Sloan Kettering Cancer Center | 2017-09-12 |
| Development of Clinical and Biological Database (NCT03449264) | Institut du Cancer de Montpellier - Val d'Aurelle | 2017-07-27 |
| Genetically Engineered PBMC and PBSC Expressing NY-ESO-1 TCR After a Myeloablative Conditioning Regimen to Treat Patients With Advanced Cancer (NCT03240861) | Jonsson Comprehensive Cancer Center | 2017-07-26 |
| Secured Access to Pembrolizumab for Patients With Selected Rare Cancer Types (NCT03012620) | UNICANCER | 2017-07-05 |
| Dose-Escalation and Expansion Trial of NC-6300 in Patients With Advanced Solid Tumors or Soft Tissue Sarcoma (NCT03168061) | NanoCarrier Co., Ltd. | 2017-06-30 |
| PAZIT Study for Children and Young Adults With Relapsed or Refractory Sarcoma (NCT03139331) | University of California, San Francisco | 2017-06-06 |
| Mobile Self Management and Support for Adolescents and Young Adults With Cancer (NCT03130751) | University of California, Los Angeles | 2017-05-23 |
| Sarcoma Treatment Guide in Improving Self-Monitoring in Patients With Sarcoma Receiving Chemotherapy (NCT03258892) | Ohio State University Comprehensive Cancer Center | 2017-05-16 |
| Trial of Nab-paclitaxel in Patients With Desmoid Tumors and Multiply Relapsed/Refractory Desmoplastic Small Round Cell Tumors and Ewing Sarcoma (NCT03275818) | Grupo Espanol de Investigacion en Sarcomas | 2017-05-09 |
| A Study of Talimogene Laherparepvec (T-VEC) in Combination With Pembrolizumab in Patients With Metastatic and/or Locally Advanced Sarcoma (NCT03069378) | Memorial Sloan Kettering Cancer Center | 2017-03-03 |
| Effectiveness of Lay Navigators in Meeting Cancer Patients' Non-Clinical Needs: A Pilot Study (NCT03245788) | Stanford University | 2017-02-15 |
| Hypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk Wall (NCT03651375) | Maria Sklodowska-Curie National Research Institute of Oncology | 2017-02-11 |
| A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6 (NCT03058289) | Intensity Therapeutics, Inc. | 2017-02-09 |
| A Study of Pemetrexed Plus Cisplatin in Patients With Refractory Soft Tissue Sarcoma (NCT03809637) | Yonsei University | 2017-01-10 |
| Prospective Biobanking Study in Cancer Patients Aiming at Better Understand the Link Between the Molecular Alterations of the Tumor Itself, Its Microenvironment and Immune Response (SCANDARE) (NCT03017573) | Institut Curie | 2017-01-06 |
| Stereotactic Body Radiotherapy (SBRT) for Pulmonary Metastases in Ewing Sarcoma, Rhabdomyosarcoma, and Wilms Tumors (NCT02581384) | Dana-Farber Cancer Institute | 2017-01-01 |
| A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers (NCT02643303) | Ludwig Institute for Cancer Research | 2016-12-28 |
| Decitabine and Gemcitabine for Pancreatic Cancer and Sarcoma (NCT02959164) | Mohammed Milhem | 2016-12-05 |
| Pembrolizumab and Doxorubicin Hydrochloride in Treating Patients With Sarcoma That is Metastatic or Cannot Be Removed by Surgery (NCT02888665) | Fred Hutchinson Cancer Center | 2016-12-05 |
| HIFU Hyperthermia With Liposomal Doxorubicin (DOXIL) for Relapsed or Refractory Pediatric and Young Adult Solid Tumors (NCT02557854) | Theodore Laetsch | 2016-12-01 |
| Adoptive Therapy Using Antigen-Specific CD4 T-Cells (NCT02210104) | M.D. Anderson Cancer Center | 2016-12-01 |
| Patient Reported Outcome Measures (PROMs) With Trabectedin (NCT03959033) | University of Leeds | 2016-11-29 |
| Co-treatment With GnRH Analogs on the Ovarian Reserve in Young Women Treated With Alkylating Agents for Cancer (NCT02856048) | Assistance Publique - Hôpitaux de Paris | 2016-11-23 |
| Enapotamab Vedotin (HuMax-AXL-ADC) Safety Study in Patients With Solid Tumors (NCT02988817) | Genmab | 2016-11-23 |
| Establishment of a Prospective Clinical-biological Database (NCT04458792) | Institut du Cancer de Montpellier - Val d'Aurelle | 2016-11-01 |
| Palbociclib With Cisplatin or Carboplatin in Advanced Solid Tumors (NCT02897375) | Emory University | 2016-10-24 |
| Negative Pressure Dressing Therapy in Soft Tissue Sarcoma Surgery (NCT02901405) | NHS Greater Glasgow and Clyde | 2016-10-18 |
| Nurse-Driven Telephone Intervention in Improving Side Effects in Cancer Patients Undergoing Chemotherapy (NCT03964896) | M.D. Anderson Cancer Center | 2016-10-17 |
| Pbi-shRNA™ EWS/FLI1 Type 1 LPX in Subjects With Advanced Ewing's Sarcoma (NCT02736565) | Gradalis, Inc. | 2016-10-01 |
| Tumour and HEalthy Tissues DOse-response and Radiosensitivity Assay (NCT02797405) | Centre Leon Berard | 2016-10-01 |
| Thermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Compressing the Spinal Cord (NCT02713269) | M.D. Anderson Cancer Center | 2016-08-29 |
| Adjuvant Oral Decitabine and Tetrahydrouridine With or Without Celecoxib in People Undergoing Pulmonary Metastasectomy (NCT02839694) | National Cancer Institute (NCI) | 2016-07-07 |
| Study of Abemaciclib in Dedifferentiated Liposarcoma (NCT02846987) | Memorial Sloan Kettering Cancer Center | 2016-07-01 |
| A Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Patients With Solid Tumors or Lymphoma (Toca 6) (NCT02576665) | Tocagen Inc. | 2016-07-01 |
| Using a Patient-Centered mHealth Intervention to Improve Adherence to Oral Anticancer Medications (NCT02833246) | Memorial Sloan Kettering Cancer Center | 2016-06-28 |
| Clinical Study of Concurrent Pazopanib and Radiotherapy for Non-metastatic Sarcoma Patients (NCT02575066) | The Netherlands Cancer Institute | 2016-03-17 |
| Advanced MR Imaging in Sarcoma Patients (NCT02705391) | Mayo Clinic | 2016-03-01 |
| A Dose Escalation Study Of PF-06801591 In Melanoma, Head And Neck Cancer (SCCHN), Ovarian, Sarcoma, Non-Small Cell Lung Cancer, Urothelial Carcinoma or Other Solid Tumors (NCT02573259) | Pfizer | 2016-02-10 |
| Expectations and Priorities of Elderly Patients for a First Medical Treatment for Cancer (NCT02821793) | Institut Bergonié | 2016-01-01 |
| Preoperative IMRT for Soft Tissue Sarcoma of the Extremities and Trunk: Low Rate of Wound Complications (NCT02785692) | Balgrist University Hospital | 2016-01-01 |
| Functional Muscle Transfers in Lower Limb Sarcoma: 3D Gait Analysis and Environmental Simulation (NCT04911972) | NHS Greater Glasgow and Clyde | 2016-01-01 |
| Incisional Negative Pressure Wound Therapy for Preoperatively Irradiated Lower Extremity Soft Tissue Sarcoma Wounds (NCT02638298) | Medical University of South Carolina | 2015-12-01 |
| PLX3397 Plus Sirolimus in Unresectable Sarcoma and Malignant Peripheral Nerve Sheath Tumors (NCT02584647) | Gulam Manji | 2015-11-04 |
| Patient-Derived Xenograft (PDX) Modeling in Adult Patients With Metastatic or Recurrent Sarcoma (NCT02720796) | Champions Oncology | 2015-11-01 |
| A Study of DSP-7888 Dosing Emulsion in Adult Patients With Advanced Malignancies (NCT02498665) | Sumitomo Pharma America, Inc. | 2015-11-01 |
| Oncology Dashboard for the Improvement of Operational Efficiency and Patients Outcomes in Patients With Sarcoma (NCT05216029) | M.D. Anderson Cancer Center | 2015-10-01 |
| Quantitative Imaging Biomarkers for Sarcoma (NCT02579980) | Columbia University | 2015-10-01 |
| Pazopanib Maintenance Phase II (NCT02207309) | Ludwig-Maximilians - University of Munich | 2015-06-22 |
| Combination of MK3475 and Metronomic Cyclophosphamide in Patients With Advanced Sarcomas : Multicentre Phase II Trial (NCT02406781) | Institut Bergonié | 2015-06-01 |
| Three Versus Five Years of Adjuvant Imatinib as Treatment of Patients With Operable GIST (NCT02413736) | Heikki Joensuu | 2015-05-01 |
| Study to Compare the Safety and Efficacy of CMB305 With Atezolizumab to Atezolizumab Alone in Participants With Sarcoma (IMDZ-C232/V943A-002) (NCT02609984) | Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2015-04-29 |
| Strain Echocardiography to Predict Cardiotoxicity in Patients Receiving Chemotherapy Containing Doxorubicin (NCT02423356) | Daniel Rushing | 2015-04-23 |
| Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer (NCT02298959) | National Cancer Institute (NCI) | 2015-04-08 |
| Pharmacometabolomic of Trabectedin in Soft Tissue Patients (NCT04394728) | Centro di Riferimento Oncologico - Aviano | 2015-04-01 |
| National Swiss Sarcoma Cohort Study (NCT02775799) | Balgrist University Hospital | 2015-04-01 |
| In Situ, Autologous Therapeutic Vaccination Against Solid Cancers With Intratumoral Hiltonol® (NCT02423863) | Oncovir, Inc. | 2015-03-01 |
| A Pilot RCT of the PRISM Intervention for AYAs With Cancer (NCT02340884) | Seattle Children's Hospital | 2015-01-30 |
| ODSH + ICE Chemotherapy in Pediatric Solid Tumors (NCT02164097) | New York Medical College | 2015-01-01 |
| NY-ESO-1-Specific T-cells in Treating Patients With Advanced NY-ESO-1-Expressing Sarcomas Receiving Palliative Radiation Therapy (NCT02319824) | Fred Hutchinson Cancer Center | 2015-01-01 |
| Hyper-Thermia Enhanced Anti-tumor Efficacy of Trabectedin (NCT02359474) | Ludwig-Maximilians - University of Munich | 2014-12-19 |
| Regorafenib in Patients With Metastatic Solid Tumors Who Have Progressed After Standard Therapy (NCT02307500) | Istituto Clinico Humanitas | 2014-12-01 |
| Study of Pembrolizumab Plus Chemotherapy in Patients With Advanced Cancer (PembroPlus) (NCT02331251) | Western Regional Medical Center | 2014-12-01 |
| PET Imaging of Solid Tumors Using 124I-Humanized 3F8: A Pilot Study (NCT02307630) | Memorial Sloan Kettering Cancer Center | 2014-11-01 |
| Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies (NCT02223052) | Celgene | 2014-10-27 |
| Magnetic Resonance Imaging or Ultrasound in Soft Tissue Tumors (MUSTT) (NCT02834585) | University of Genova | 2014-10-01 |
| Dendritic Cell-based Immunotherapy for Advanced Solid Tumours of Children and Young Adults (NCT02496520) | Clinica Universidad de Navarra, Universidad de Navarra | 2014-09-30 |